Literature DB >> 11506189

Helicobacter infection and phospholipase A2 enzymes: effect of Helicobacter felis-infection on the expression and activity of sPLA2 enzymes in mouse stomach.

A Ottlecz1, J J Romero, L M Lichtenberger.   

Abstract

The murine gastric mucosa possesses very high secretory type phospholipase A2 activity. Northern and Western blots indicated that the pancreatic-type, sPLA2-IB represents the predominant form of sPLA2 enzymes present in the gastric mucosa. Both sPLA2-IB mRNA and protein in the gastric mucosa exceeded levels found in the pancreas, and in contrast to the pancreatic enzyme it was present primarily in the active state. The sPLA2-IB gene is not expressed in the murine small intestine and colon. Infection by the gastritis-inducing bacteria, Helicobacterfelis (H. felis) dramatically and time dependently decreased the PLA2 activity in the glandular stomach of the mouse strain, C57BL/6, sensitive to the organism, which appeared to be related to a decrease in the percentage of sPLA2-IB present in the active form. This bacterial-induced reduction in PLA2 activity was not observed in BALB/c mice that fail to develop gastritis in response to H. felis infection. C57BL/6 mice do not, while BALB/c mice express, the PLA2-II enzyme. The H. felis-induced reduction in sPLA2-IB activity may weaken the gastric barrier by reducing the local concentration of arachidonic and linoleic acid, liberated from membrane phospholipids, the major precursors of 'cytoprotective' prostaglandins. Data presented here suggest that both sPLA2-IB and sPLA2-II enzymes may contribute to the gastric response to Helicobacter infection.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11506189     DOI: 10.1023/a:1010971910866

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  33 in total

Review 1.  Epithelial cells as sensors for microbial infection.

Authors:  M F Kagnoff; L Eckmann
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

2.  Presence of pancreatic-type phospholipase A2 mRNA in rat gastric mucosa and lung.

Authors:  T Sakata; E Nakamura; Y Tsuruta; M Tamaki; H Teraoka; H Tojo; T Ono; M Okamoto
Journal:  Biochim Biophys Acta       Date:  1989-01-23

3.  Phospholipase A2 activity of rat stomach.

Authors:  R Grataroli; M Charbonnier; J Léonardi; J C Grimaud; H Lafont; G Nalbone
Journal:  Arch Biochem Biophys       Date:  1987-10       Impact factor: 4.013

4.  Pancreatic phospholipase A2: isolation of the human gene and cDNAs from porcine pancreas and human lung.

Authors:  J J Seilhamer; T L Randall; M Yamanaka; L K Johnson
Journal:  DNA       Date:  1986-12

Review 5.  Regulation and inhibition of phospholipase A2.

Authors:  J Balsinde; M A Balboa; P A Insel; E A Dennis
Journal:  Annu Rev Pharmacol Toxicol       Date:  1999       Impact factor: 13.820

Review 6.  New insights on mammalian phospholipase A2(s); comparison of arachidonoyl-selective and -nonselective enzymes.

Authors:  R J Mayer; L A Marshall
Journal:  FASEB J       Date:  1993-02-01       Impact factor: 5.191

7.  The potent anti-Staphylococcus aureus activity of a sterile rabbit inflammatory fluid is due to a 14-kD phospholipase A2.

Authors:  Y Weinrauch; P Elsbach; L M Madsen; A Foreman; J Weiss
Journal:  J Clin Invest       Date:  1996-01-01       Impact factor: 14.808

8.  Hypertrophic gastropathy in Helicobacter felis-infected wild-type C57BL/6 mice and p53 hemizygous transgenic mice.

Authors:  J G Fox; X Li; R J Cahill; K Andrutis; A K Rustgi; R Odze; T C Wang
Journal:  Gastroenterology       Date:  1996-01       Impact factor: 22.682

9.  The secretory phospholipase A2 gene is a candidate for the Mom1 locus, a major modifier of ApcMin-induced intestinal neoplasia.

Authors:  M MacPhee; K P Chepenik; R A Liddell; K K Nelson; L D Siracusa; A M Buchberg
Journal:  Cell       Date:  1995-06-16       Impact factor: 41.582

10.  Bactericidal properties of murine intestinal phospholipase A2.

Authors:  S S Harwig; L Tan; X D Qu; Y Cho; P B Eisenhauer; R I Lehrer
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

View more
  2 in total

1.  Advent of novel phosphatidylcholine-associated nonsteroidal anti-inflammatory drugs with improved gastrointestinal safety.

Authors:  Yun Jeong Lim; Elizabeth J Dial; Lenard M Lichtenberger
Journal:  Gut Liver       Date:  2012-11-13       Impact factor: 4.519

2.  Mouse models of gastric cancer.

Authors:  Yoku Hayakawa; James G Fox; Tamas Gonda; Daniel L Worthley; Sureshkumar Muthupalani; Timothy C Wang
Journal:  Cancers (Basel)       Date:  2013-01-24       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.